drugset / Trial / NCT00799708

A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(COMPLETED)

NCT00799708

Phase 1 Completed 27 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindDiagnostic

Summary

This study will develop a model for the assessment of successful activation/engagement of estrogen receptor beta using salivary biomarkers.

Timeline

Start
2008-05
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Estradiol Other / unclassified 0.5 mg
Comparator Estradiol Other / unclassified 2 mg

Indications

No indication recorded.